cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Greenlight Biosciences Holding
2 own
2 watching
Current Price
$1.11
$-0.01
(-0.89%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
168.13M
52-Week High
52-Week High
15.8
52-Week Low
52-Week Low
1
Average Volume
Average Volume
0.22M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization168.13M
icon52-Week High15.8
icon52-Week Low1
iconAverage Volume0.22M
iconDividend Yield--
iconP/E Ratio--
What does the Greenlight Biosciences Holding do?
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
Read More
News & Events about Greenlight Biosciences Holding.
Globe Newswire
26days ago
GreenLight GreenLights mRNA design, formulation and manufacturing expertise is currently applied to research and develop mRNA vaccine candidates The effort will combine GreenLights mRNA design and manufacturing expertise with EpiVaxs advanced Ancer pipeline for personalized cancer vaccine ...
Globe Newswire
2 months ago
Credit Suisse annual conference GreenLight CEO Andrey Zarur will present to the Credit Suisse 31st Annual Healthcare Conference BOSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the potential of RNA to address some...
Globe Newswire
4 months ago
Fall armyworm GreenLight's plant health research team is working to develop a solution to fall armyworm GreenLight Biosciences and Queensland University of Technology (QUT) partner to create a solution for fall armywormFall armyworm is one of the most destructive insect pests on the planet, ...
Globe Newswire
5 months ago
GreenLight human health research labs GreenLight Biosciences Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress GreenLight raised $108.4 million in private placement led by S2G Ventures with strong participation from existing and new investors with cash ...
Globe Newswire
5 months ago
GLB456 GreenLight intends to use the net proceeds from the financing to advance its development of research and commercial programs BOSTON, Aug. 12, 2022 (GLOBE NEWSWIRE) -- GreenLightBiosciences (Nasdaq: GRNA), a public benefit corporation striving to bring effective and safe solutions to make ...
Frequently Asked Questions
Frequently Asked Questions
What is Greenlight Biosciences Holding share price today?
plus_minus_icon
Can Indians buy Greenlight Biosciences Holding shares?
plus_minus_icon
How can I buy Greenlight Biosciences Holding shares from India?
plus_minus_icon
Can Fractional shares of Greenlight Biosciences Holding be purchased?
plus_minus_icon
What are the documents required to start investing in Greenlight Biosciences Holding stocks?
plus_minus_icon
What is today’s traded volume of Greenlight Biosciences Holding?
plus_minus_icon
What is today’s market capitalisation of Greenlight Biosciences Holding?
plus_minus_icon
What is the 52-Week High and Low Range of Greenlight Biosciences Holding?
plus_minus_icon
What percentage is Greenlight Biosciences Holding down from its 52-Week High?
plus_minus_icon
What percentage is Greenlight Biosciences Holding up from its 52-Week Low?
plus_minus_icon
Current Price
$1.11
$-0.01
(-0.89%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00